NANOPHASE TECHNOLOGIES Corp 4
4 · NANOPHASE TECHNOLOGIES Corp · Filed Feb 24, 2016
Insider Transaction Report
Form 4
CESARIO FRANK
Chief Financial Officer
Transactions
- Award
Common Stock
2016-02-23$0.42/sh+31,500$13,230→ 31,500 totalExercise: $0.42From: 2017-02-23Exp: 2026-02-23→ Common Stock (31,500 underlying)
Holdings
- 83,783
Common Stock
- 40,000
Common Stock (right to buy)
Exercise: $0.52From: 2015-02-13Exp: 2024-02-13→ Common Stock (40,000 underlying) - 20,000
Common Stock (right to buy)
Exercise: $1.70From: 2011-05-03Exp: 2020-05-03→ Common Stock (20,000 underlying) - 13,667
Common Stock (right to buy)
Exercise: $0.30From: 2013-08-07Exp: 2022-08-07→ Common Stock (13,667 underlying) - 20,000
Common Stock (right to buy)
Exercise: $1.07From: 2010-06-24Exp: 2019-06-24→ Common Stock (20,000 underlying) - 31,000
Common Stock (right to buy)
Exercise: $1.26From: 2012-05-02Exp: 2021-05-02→ Common Stock (31,000 underlying) - 13,000
Common Stock (right to buy)
Exercise: $0.41From: 2014-02-14Exp: 2023-02-14→ Common Stock (13,000 underlying) - 36,000
Common Stock (right to buy)
Exercise: $0.44From: 2016-02-18Exp: 2025-02-18→ Common Stock (36,000 underlying)
Footnotes (1)
- [F1]Subject to certain restrictions, beginning on this date, options vest in three equal annual installments.